3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
12
Brain Neoplasms
3
Urogenital Diseases
2
Neoplasms
2
Disease
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Cancer
1
Carcinoma, Transitional Cell
1
Carcinoma, Lobular
1
Interventions
Paclitaxel
22
Carboplatin
18
liposomal doxorubicin
14
Bevacizumab
9
Topotecan
8
Docetaxel
8
Gemcitabine
7
Cisplatin
7
rucaparib
6
pembrolizumab
6
mirvetuximab soravtansine
5
Cyclophosphamide
5
Taxes
4
Albumin-Bound Paclitaxel
4
sargramostim
3
ixabepilone
3
Cytoreduction Surgical Procedures
3
CCV-AV protocol
3
130-nm albumin-bound paclitaxel
3
taxane
2
talazoparib
2
pazopanib
2
olaparib
2
fludarabine phosphate
2
fludarabine
2
denileukin diftitox
2
cediranib
2
catumaxomab
2
belinostat
2
avelumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Ovarian Epithelial
×
fluciclovine F-18
×
Clear all
No trials found.